Percutaneous treatment of mitral valve disease

Dr. Igor F. Palacios

Percutaneous treatment of mitral valve disease

Autores/as

Dr. Igor F. Palacios Director of Interventional Cardiology Massachusetts General Hospital Professor of Medicine Harvard Medical School

Resumen

Mitral valve disease is one of the most commonvalvular heart conditions. A true incidence ofmitral valve disease is unknown (1,2). Theprevalence of rheumatic disease in developedcountries is declining with an estimated incidenceof 1 in 100 000.

Descargas

Los datos de descargas todavía no están disponibles.

Descargas

Cómo citar

Palacios, D. I. F. (2020). Percutaneous treatment of mitral valve disease. Gaceta Médica De Caracas, 126(4), 345–362. Recuperado a partir de http://repositoriolinux.ucv.ve/ojs/index.php/rev_gmc/article/view/17315